ES2162560A1 - Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia. - Google Patents
Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia.Info
- Publication number
- ES2162560A1 ES2162560A1 ES009901286A ES9901286A ES2162560A1 ES 2162560 A1 ES2162560 A1 ES 2162560A1 ES 009901286 A ES009901286 A ES 009901286A ES 9901286 A ES9901286 A ES 9901286A ES 2162560 A1 ES2162560 A1 ES 2162560A1
- Authority
- ES
- Spain
- Prior art keywords
- srsi
- paroxetine
- fluoxetine
- refrain
- medicaments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Los inhibidores selectivos de la recaptación de serotonina (ISRS), como la fluoxetina, paroxetina, fluvoxamina, sertralina, etc. poseen la capacidad de disminuir las obsesiones; dado que hemos comprobado que las toxicomanías y otras dependencias reúnen características que guardan una gran semejanza con las obsesiones, consideramos que dichas sustancias pueden ser utilizadas en una forma nueva: para aumentar la capacidad de las personas de abstenerse de tóxicos o actividades que les hayan provocado una dependencia, aumentando así el tiempo de abstinencia conseguido en los tratamientos actuales y evitando las recaídas.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009901286A ES2162560B1 (es) | 1999-06-25 | 1999-06-25 | Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia. |
PCT/ES2000/000219 WO2001000202A1 (es) | 1999-06-25 | 2000-06-22 | Utilizacion de fluoxetina, paroxetina y otros isrs como medicamentos para aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES009901286A ES2162560B1 (es) | 1999-06-25 | 1999-06-25 | Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2162560A1 true ES2162560A1 (es) | 2001-12-16 |
ES2162560B1 ES2162560B1 (es) | 2002-07-16 |
Family
ID=8308783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES009901286A Expired - Lifetime ES2162560B1 (es) | 1999-06-25 | 1999-06-25 | Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia. |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES2162560B1 (es) |
WO (1) | WO2001000202A1 (es) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5250572A (en) * | 1990-03-29 | 1993-10-05 | Eli Lilly And Company | (R)-norfluoxetine in method for occupying serotonin IC receptors |
WO1997003670A1 (en) * | 1995-07-20 | 1997-02-06 | Smithkline Beecham P.L.C. | Paroxetine controlled release compositions |
US5708035A (en) * | 1991-02-04 | 1998-01-13 | Sepracor Inc. | Methods of use and compositions of R(-) fluoxetine |
WO1998031365A1 (en) * | 1997-01-15 | 1998-07-23 | Smithkline Beecham Plc | Paroxetine compositions |
FR2763846A1 (fr) * | 1997-05-29 | 1998-12-04 | Lilly Co Eli | Pilules de fluoxetine enteriques |
-
1999
- 1999-06-25 ES ES009901286A patent/ES2162560B1/es not_active Expired - Lifetime
-
2000
- 2000-06-22 WO PCT/ES2000/000219 patent/WO2001000202A1/es active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5250572A (en) * | 1990-03-29 | 1993-10-05 | Eli Lilly And Company | (R)-norfluoxetine in method for occupying serotonin IC receptors |
US5708035A (en) * | 1991-02-04 | 1998-01-13 | Sepracor Inc. | Methods of use and compositions of R(-) fluoxetine |
WO1997003670A1 (en) * | 1995-07-20 | 1997-02-06 | Smithkline Beecham P.L.C. | Paroxetine controlled release compositions |
WO1998031365A1 (en) * | 1997-01-15 | 1998-07-23 | Smithkline Beecham Plc | Paroxetine compositions |
FR2763846A1 (fr) * | 1997-05-29 | 1998-12-04 | Lilly Co Eli | Pilules de fluoxetine enteriques |
Also Published As
Publication number | Publication date |
---|---|
ES2162560B1 (es) | 2002-07-16 |
WO2001000202A1 (es) | 2001-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200301813B (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them. | |
BG104780A (en) | Inhibitors of phospholipase enzymes | |
HUP0201214A3 (en) | Inhibitors of impdh enzyme, pharmaceutical compositions containing them and their use | |
HUP0200355A3 (en) | 4-aminopyrrolopyrimidines as kinase inhibitors, pharmaceutical compositions containing them and their use | |
IL151313A0 (en) | Lipase containing pharmaceutical compositions | |
MY133996A (en) | Compounds for the treatment of ischemia | |
AU3652102A (en) | Compounds and their uses | |
HUP0500574A3 (en) | Acridone inhibitors of impdh enzyme, pharmaceutical compositions containing them and their use | |
MY122771A (en) | Heterocyclically substituted benzimidazoles, their preparation and use thereof | |
ZA200108082B (en) | Pharmaceutical compositions comprising dipeptidy peptidase IV inhibitors for the promotion of growth. | |
MXPA02005602A (es) | Compuestos de urea que tienen actividad antagonista para el receptor muscarinico. | |
BR9911724A (pt) | Ciclosporina que tem um perfil de atividade melhorado | |
HUP0103283A3 (en) | Pyrazinone protease inhibitors, pharmaceutical compositions containing them and use of the compounds | |
BR0110961A (pt) | Derivados de triazol | |
AU2002220715A1 (en) | Indolsulfonyl compounds useful in the treatment of cns disorders | |
IT1299317B1 (it) | Pacchetto di sigarette. | |
MY129668A (en) | Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes | |
MXPA03010158A (es) | Sulfonamidas. | |
HUP0103431A3 (en) | Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent | |
EA200000165A1 (ru) | Разветвленные алкоксизамещенные-2-аминопиридины в качестве ингибиторов nos | |
IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
EP1246619A4 (en) | UROTENSIN II RECEPTOR ANTAGONISTS | |
ES2193105T3 (es) | Caramelos duros de estabilidad mejorada al almacenaje. | |
ES2162560A1 (es) | Uso de fluoxetina, paroxetina y otros isrs para la fabricacion de medicamentos con el fin de aumentar la capacidad de abstenerse de substancias o actividades que crean dependencia. | |
FR2873377B1 (fr) | Derives d'azasucre, inhibiteurs d'heparanases, leur procede de preparation, les compositions en contenant et leur utilisation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 20011216 Kind code of ref document: A1 Effective date: 20011216 |
|
FA2A | Application withdrawn |
Effective date: 20031120 |